Harnessing post-translational modifications for a tuberculosis booster vaccine

FHS
June 19, 2024
4:26 pm

Tuberculosis is still one of the deadliest infectious diseases, causing over one million deaths each year worldwide.

Kuano closes £1.8M seed funding round to validate quantum simulation platform for drug discovery

Kuano, a drug discovery company combining quantum mechanics with AI to design the next generation of medicines, today announced the close of its £1.8M seed

September 13, 2023

Anakinra shows promise in reducing symptoms in patients with Sanfilippo syndrome

As a neurodegenerative disease characterized by childhood onset dementia, Sanfilippo syndrome causes immense suffering in many ways, including pain, loss of speech, extreme agitation, and

June 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Harnessing post-translational modifications for a tuberculosis booster vaccine

Kuano closes £1.8M seed funding round to validate quantum simulation platform for drug discovery

Anakinra shows promise in reducing symptoms in patients with Sanfilippo syndrome

Exclusive: Social Security chief vows to fix ‘cruel-hearted’ overpayment clawbacks

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe